Radiopharm Theranostics (RADX) Short Interest Ratio & Short Volume

Short interest is the volume of Radiopharm Theranostics shares that have been sold short but have not yet been closed out or covered. As of September 15th, investors have sold 44,100 shares of RADX short. Learn More on Radiopharm Theranostics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RADX shares currently have a short interest ratio of 2.0. Learn More on Radiopharm Theranostics's short interest ratio.

Radiopharm Theranostics saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 44,100 shares, an increase of 0.7% from the previous total of 43,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "med - biomed/gene" compare to Radiopharm Theranostics: Forte Biosciences, Inc. (1.06%), Seres Therapeutics, Inc. (14.47%), SELLAS Life Sciences Group, Inc. (19.84%), Milestone Pharmaceuticals Inc. (6.95%), MaxCyte, Inc. (3.64%), Genelux Corporation (6.71%), Citius Oncology, Inc. (1.23%), Actuate Therapeutics, Inc. (8.00%), Eledon Pharmaceuticals, Inc. (9.07%), Theratechnologies Inc. (0.51%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks.

Short selling RADX is an investing strategy that aims to generate trading profit from Radiopharm Theranostics as its price is falling. RADX shares are trading up $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Radiopharm Theranostics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RADX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RADX, twice per month. The most recent reporting period available is September, 15 2025.